home · filing · 0001477449-24-000157
8-K filed June 10, 2024, 7:59 PM ET
ticker TDOC
CIK 0001477449
leadership
confidence high
sentiment neutral
materiality 0.75
Teladoc Health names Chuck Divita as CEO effective June 10, 2024
Teladoc Health, Inc.
Charles Divita appointed CEO and board member; Mala Murthy returns to CFO role.
Divita previously EVP Commercial Markets at GuideWell/Florida Blue, overseeing $23B in revenue.
New-hire equity award valued at ~$15M: 939,849 PSUs and 469,924 RSUs; base salary $800,000.
Company amended 2023 Inducement Plan, increasing reserved shares by 4M to 4.5M for CEO grants.
Mala Murthy's severance agreement amended to provide two years of enhanced severance protections.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Charles Divita, III
Director
TDOC ·
Teladoc Health, Inc.
Effective 2024-06-10
Filed June 10, 2024, 7:59 PM ET
appointed Mr. Divita as a director of the Company.
Appointed
Charles Divita, III
Chief Executive Officer
TDOC ·
Teladoc Health, Inc.
Effective 2024-06-10
Filed June 10, 2024, 7:59 PM ET
Charles Divita, III joined Teladoc Health, Inc. (the “Company”) as its Chief Executive Officer.
Role change
Mala Murthy
Chief Financial Officer
TDOC ·
Teladoc Health, Inc.
Effective 2024-06-10
Successor Charles Divita, III
Filed June 10, 2024, 7:59 PM ET
Mala Murthy stepped down as acting Chief Executive Officer of the Company and will remain the Company's Chief Financial Officer.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Charles Divita, III was appointed as Director at Teladoc Health, Inc..
Action appointed
Role Director
Exact text from the filing
appointed Mr. Divita as a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Charles Divita, III was appointed as Chief Executive Officer at Teladoc Health, Inc..
Action joined
Role Chief Executive Officer
Exact text from the filing
Charles Divita, III joined Teladoc Health, Inc. (the “Company”) as its Chief Executive Officer.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Mala Murthy changed role as Chief Financial Officer at Teladoc Health, Inc..
Action stepped down as acting Chief Executive Officer
Role Chief Financial Officer
Exact text from the filing
Mala Murthy stepped down as acting Chief Executive Officer of the Company and will remain the Company's Chief Financial Officer.
View on SEC.gov
Source: SEC EDGAR
accession 0001477449-24-000157
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.